HeartBeam, Inc. ( BEAT) Stock. Should you Buy or Sell? $ 1.33
0.05 (3.62 %)
HeartBeam, Inc. AnalysisUpdated on 10-09-2022
|Volume Avg.||$96.38 thousand|
|Market Cap||$10.63 M|
|52 Week Range||$1.12 - $5.47|
HeartBeam, Inc. opened the day at $1.33 which is +'3.62 % on yesterday's close. HeartBeam, Inc. has a 52 week high of $5.47 and 52 week low of $1.12, which is a difference of $4.35. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $10.63 M and total net profit is $0 which means the company is trading at inf times profit to market capitalization. Theoretically, if you were to buy HeartBeam, Inc. for $10.63 M, it would take 15 years to get your money back. HeartBeam, Inc. are in the Health Information Services space which will have a sweet spot and industry standard for net profit multiples.
HeartBeam, Inc. Stock Forecast - Is HeartBeam, Inc. a Buy or Sell?
|DCF Score||Strong Buy|
|ROE Score||Strong Sell|
|ROA Score||Strong Sell|
|PB Score||Strong Buy|
Growth and Value
|Net Profit Margin||0.000|
Valuing HeartBeam, Inc.
|Price Book Value Ratio||1.208||Price To Book Ratio||1.208|
|Price To Sales Ratio||0.000||Price Earnings Ratio||-2.290|
How liquid is HeartBeam, Inc.
|Debt Ratio||0.079||Debt Equity Ratio||0.086|
|Long Term Debt To Capitalization||0.000||Total Debt To Capitalization||0.000|
Latest news about HeartBeam, Inc.
HeartBeam, Inc. (NASDAQ:BEAT ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Branislav Vajdic - Chief Executive Officer & Founder Jon Hunt - Chief Business Officer Rick Brounstein - Chief Financial Officer Conference Call Participants Bill Sutherland - The Benchmark Company Jason Kolbert - Dawson James Operator Greetings and welcome to the HeartBeam Second Quarter 2022 Financial Results Conference Call. At this time, all participants will be in a listen-only mode.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Second Quarter 2022 Results Conference Call on Thursday August 11, 2022 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Present at LD Micro Invitational XII Conference on June 7, 2022
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Participate in the H.C. Wainwright Global Investment Conference May 23-26, 2022
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2022 Results Conference Call on Thursday May 12, 2022 at 4:30 p.m. Eastern Time
About HeartBeam, Inc.
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.